Symbols / SLGL Stock $76.22 -4.73% Sol-Gel Technologies Ltd.
SLGL (Stock) Chart
Stock Fundamentals
|
|
|
|
|
|
About
Official websiteSol-Gel Technologies Ltd., together with its subsidiary Sol-Gel Technologies Inc., develops topical dermatological drugs for patients with severe skin conditions in Israel, China, Switzerland, Canada, the United States and internationally. The company offers Twyneo, a once-daily, non-antibiotic topical cream for the treatment of acne vulgaris; and Epsolay, a once-daily topical cream for the treatment of papulopustular (subtype II) rosacea. It also develops SGT-610 that is in Phase 3 clinical trials for the treatment of Gorlin Syndrome; and SGT-210, which has completed Phase I clinical trial, to treat olmsted syndrome. It has collaboration with Padagis Israel Pharmaceuticals Ltd; and license agreements with Galderma Holding SA and Searchlight Pharma Inc. Sol-Gel Technologies Ltd. was incorporated in 1997 and is headquartered in Ness Ziona, Israel.
Ratings
Current target
$76.22
Low
$110.00
High
$184.00
Mean
$147.00
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2026-01-20 | main | HC Wainwright & Co. | Buy → Buy | $110 |
| 2025-12-22 | reit | HC Wainwright & Co. | Buy → Buy | $50 |
| 2025-10-27 | main | HC Wainwright & Co. | Buy → Buy | $50 |
| 2024-08-19 | down | Raymond James | Strong Buy → Outperform | $4 |
| 2024-05-22 | reit | HC Wainwright & Co. | Buy → Buy | $6 |
| 2024-05-20 | main | HC Wainwright & Co. | Buy → Buy | $6 |
| 2023-11-13 | main | HC Wainwright & Co. | Buy → Buy | $9 |
| 2023-08-14 | main | HC Wainwright & Co. | Buy → Buy | $12 |
| 2023-08-11 | main | Raymond James | Strong Buy → Strong Buy | $7 |
| 2023-07-24 | reit | HC Wainwright & Co. | Buy → Buy | $19 |
| 2023-07-19 | main | Raymond James | Strong Buy → Strong Buy | $9 |
| 2023-06-05 | reit | HC Wainwright & Co. | Buy → Buy | $19 |
| 2023-04-12 | reit | HC Wainwright & Co. | — → Buy | $19 |
| 2023-03-14 | main | Raymond James | — → Strong Buy | $10 |
| 2023-02-01 | reit | HC Wainwright & Co. | — → Buy | $19 |
| 2022-11-14 | main | HC Wainwright & Co. | — → Buy | $19 |
| 2022-11-11 | main | Raymond James | — → Strong Buy | $13 |
| 2022-10-21 | init | Jefferies | — → Hold | $6 |
| 2022-08-29 | main | HC Wainwright & Co. | — → Buy | $22 |
| 2022-05-16 | main | Raymond James | — → Strong Buy | $16 |
- Phoenix Financial Ltd. (SLGL) reports 4.99% ownership of Sol‑Gel shares - Stock Titan ue, 09 Jun 2026 19
- Insider Purchase: 10% owner at $SLGL Buys 1,500 Shares | SLGL Stock News - Quiver Quantitative hu, 14 May 2026 07
- Sol-Gel Technologies Ltd. (SLGL) Reports Q1 Loss, Lags Revenue Estimates - Yahoo Finance hu, 28 May 2026 07
- Should I buy SolGel Technologies (SLGL) - Zacks Investment Research hu, 28 May 2026 07
- The Technical Signals Behind (SLGL) That Institutions Follow - Stock Traders Daily hu, 21 May 2026 07
- Revenues Not Telling The Story For Sol-Gel Technologies Ltd. (NASDAQ:SLGL) After Shares Rise 30% - simplywall.st hu, 11 Dec 2025 08
- GREAT POINT PARTNERS LLC's Sol-Gel Technologies Ltd(SLGL) Holding History - GuruFocus hu, 28 May 2026 07
- Sol-Gel brings in $33.1M to fund SGT-610 development - Stock Titan Mon, 23 Mar 2026 07
- $SLGL stock is up 9% today. Here's what we see in our data. - Quiver Quantitative Mon, 26 Jan 2026 08
- Here's Why We're Not At All Concerned With Sol-Gel Technologies' (NASDAQ:SLGL) Cash Burn Situation - simplywall.st hu, 15 Jan 2026 08
- Sol-Gel wins 2044 patent for Gorlin syndrome gel, raises $33M - Stock Titan hu, 28 May 2026 07
- Sol-Gel Technologies (NASDAQ: SLGL) trims Q1 2026 loss and strengthens cash runway - Stock Titan hu, 28 May 2026 07
- Opaleye-managed fund buys 1,563 Sol-Gel (SLGL) shares in open market - Stock Titan Fri, 22 May 2026 07
- SLGL SEC Filings - Sol Gel Tech 10-K, 10-Q, 8-K Forms - Stock Titan Fri, 22 May 2026 15
- Opaleye Management (SLGL) boosts Sol-Gel stake with open-market share buys - Stock Titan hu, 14 May 2026 07
Insider Transactions
Financials
Statement View
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
19.39
+68.04%
|
11.54
+642.47%
|
1.55
-59.98%
|
3.88
|
| Operating Revenue |
|
19.39
+68.04%
|
11.54
+642.47%
|
1.55
-59.98%
|
3.88
|
| Operating Expense |
|
26.93
+14.33%
|
23.55
-23.68%
|
30.86
+53.32%
|
20.13
|
| Research And Development |
|
22.80
+28.09%
|
17.80
-24.37%
|
23.54
+85.63%
|
12.68
|
| Selling General And Administration |
|
4.18
-27.36%
|
5.75
-22.03%
|
7.37
-0.97%
|
7.45
|
| General And Administrative Expense |
|
4.18
-27.36%
|
5.75
-22.03%
|
7.37
-0.97%
|
7.45
|
| Other Gand A |
|
4.18
-27.36%
|
5.75
-22.03%
|
7.37
-0.97%
|
7.45
|
| Other Operating Expenses |
|
-0.05
|
—
|
-0.06
|
—
|
| Total Expenses |
|
26.93
+14.33%
|
23.55
-23.68%
|
30.86
+53.32%
|
20.13
|
| Operating Income |
|
-7.54
+37.26%
|
-12.01
+59.00%
|
-29.30
-80.41%
|
-16.24
|
| Total Operating Income As Reported |
|
-7.54
+37.26%
|
-12.01
+59.00%
|
-29.30
-80.41%
|
-16.24
|
| EBITDA |
|
-7.43
+36.94%
|
-11.78
+59.32%
|
-28.96
-84.69%
|
-15.68
|
| Normalized EBITDA |
|
-7.43
+36.94%
|
-11.78
+59.32%
|
-28.96
-84.69%
|
-15.68
|
| Reconciled Depreciation |
|
0.11
-53.22%
|
0.23
-31.87%
|
0.34
-39.15%
|
0.56
|
| EBIT |
|
-7.54
+37.26%
|
-12.01
+59.00%
|
-29.30
-80.41%
|
-16.24
|
| Net Income |
|
-6.13
+42.09%
|
-10.58
+61.16%
|
-27.24
-82.52%
|
-14.92
|
| Pretax Income |
|
-6.13
+42.09%
|
-10.58
+61.16%
|
-27.24
-82.52%
|
-14.92
|
| Net Non Operating Interest Income Expense |
|
1.41
-1.60%
|
1.43
-30.62%
|
2.07
+56.47%
|
1.32
|
| Net Interest Income |
|
1.41
-1.60%
|
1.43
-30.62%
|
2.07
+56.47%
|
1.32
|
| Interest Income Non Operating |
|
1.41
-1.60%
|
1.43
-30.62%
|
2.07
+56.47%
|
1.32
|
| Interest Income |
|
1.41
-1.60%
|
1.43
-30.62%
|
2.07
+56.47%
|
1.32
|
| Tax Provision |
|
—
|
—
|
—
|
—
|
| Tax Rate For Calcs |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
-6.13
+42.09%
|
-10.58
+61.16%
|
-27.24
-82.52%
|
-14.92
|
| Net Income From Continuing Operation Net Minority Interest |
|
-6.13
+42.09%
|
-10.58
+61.16%
|
-27.24
-82.52%
|
-14.92
|
| Net Income From Continuing And Discontinued Operation |
|
-6.13
+42.09%
|
-10.58
+61.16%
|
-27.24
-82.52%
|
-14.92
|
| Net Income Continuous Operations |
|
-6.13
+42.09%
|
-10.58
+61.16%
|
-27.24
-82.52%
|
-14.92
|
| Normalized Income |
|
-6.13
+42.09%
|
-10.58
+61.16%
|
-27.24
-82.52%
|
-14.92
|
| Net Income Common Stockholders |
|
-6.13
+42.09%
|
-10.58
+61.16%
|
-27.24
-82.52%
|
-14.92
|
| Diluted EPS |
|
-2.19
+42.22%
|
-3.79
+62.14%
|
-10.01
-54.00%
|
-6.50
|
| Basic EPS |
|
-2.19
+42.22%
|
-3.79
+62.14%
|
-10.01
-54.00%
|
-6.50
|
| Basic Average Shares |
|
2.79
+0.00%
|
2.79
+2.85%
|
2.71
+17.11%
|
2.31
|
| Diluted Average Shares |
|
2.79
+0.00%
|
2.79
+2.85%
|
2.71
+17.11%
|
2.31
|
| Diluted NI Availto Com Stockholders |
|
-6.13
+42.09%
|
-10.58
+61.16%
|
-27.24
-82.52%
|
-14.92
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Assets |
|
29.92
-16.54%
|
35.85
-20.85%
|
45.29
-2.88%
|
46.63
|
| Current Assets |
|
26.97
-13.82%
|
31.30
-23.98%
|
41.17
-4.39%
|
43.05
|
| Cash Cash Equivalents And Short Term Investments |
|
24.00
+0.31%
|
23.93
-37.03%
|
38.00
+13.00%
|
33.63
|
| Cash And Cash Equivalents |
|
11.03
-43.39%
|
19.49
+159.40%
|
7.51
-39.64%
|
12.45
|
| Other Short Term Investments |
|
12.97
+192.22%
|
4.44
-85.44%
|
30.48
+43.94%
|
21.18
|
| Receivables |
|
1.97
-45.26%
|
3.60
+853.58%
|
0.38
-95.24%
|
7.92
|
| Accounts Receivable |
|
1.97
-45.26%
|
3.60
+853.58%
|
0.38
+508.06%
|
0.06
|
| Other Receivables |
|
—
|
—
|
—
|
7.86
|
| Prepaid Assets |
|
—
|
—
|
—
|
—
|
| Other Current Assets |
|
1.00
-73.40%
|
3.77
+35.08%
|
2.79
+85.16%
|
1.51
|
| Total Non Current Assets |
|
2.95
-35.27%
|
4.55
+10.46%
|
4.12
+15.31%
|
3.57
|
| Net PPE |
|
1.17
-28.32%
|
1.63
-24.45%
|
2.15
+40.30%
|
1.54
|
| Gross PPE |
|
5.44
-28.91%
|
7.65
-3.86%
|
7.96
+9.78%
|
7.25
|
| Accumulated Depreciation |
|
-4.27
+29.07%
|
-6.02
-3.79%
|
-5.80
-1.58%
|
-5.71
|
| Properties |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Machinery Furniture Equipment |
|
0.75
+1.08%
|
0.74
+0.14%
|
0.74
+6.64%
|
0.69
|
| Other Properties |
|
4.22
-14.30%
|
4.93
-5.83%
|
5.24
+14.70%
|
4.56
|
| Leases |
|
0.47
-76.44%
|
1.98
-0.15%
|
1.99
-0.40%
|
1.99
|
| Non Current Accounts Receivable |
|
—
|
1.02
|
—
|
—
|
| Other Non Current Assets |
|
1.39
+6.29%
|
1.30
-2.61%
|
1.34
+3.96%
|
1.29
|
| Total Liabilities Net Minority Interest |
|
7.11
+1.57%
|
7.00
+5.31%
|
6.64
+50.46%
|
4.42
|
| Current Liabilities |
|
6.17
+16.76%
|
5.29
+16.87%
|
4.52
+35.84%
|
3.33
|
| Payables And Accrued Expenses |
|
5.68
+16.91%
|
4.86
+19.14%
|
4.08
+56.07%
|
2.61
|
| Payables |
|
2.77
-27.12%
|
3.79
+87.73%
|
2.02
+49.26%
|
1.35
|
| Accounts Payable |
|
0.73
-41.90%
|
1.26
+721.43%
|
0.15
-38.65%
|
0.25
|
| Other Payable |
|
2.03
-19.73%
|
2.53
+35.46%
|
1.87
+69.27%
|
1.10
|
| Current Accrued Expenses |
|
2.91
+174.36%
|
1.06
-48.34%
|
2.05
+63.40%
|
1.26
|
| Employee Benefits |
|
0.44
-47.30%
|
0.83
-8.96%
|
0.92
-11.34%
|
1.03
|
| Current Debt And Capital Lease Obligation |
|
0.49
+15.12%
|
0.43
-3.80%
|
0.45
-37.74%
|
0.72
|
| Current Capital Lease Obligation |
|
0.49
+15.12%
|
0.43
-3.80%
|
0.45
-37.74%
|
0.72
|
| Total Non Current Liabilities Net Minority Interest |
|
0.94
-45.35%
|
1.71
-19.33%
|
2.12
+95.30%
|
1.09
|
| Long Term Debt And Capital Lease Obligation |
|
0.50
-43.51%
|
0.88
-27.20%
|
1.21
+2133.33%
|
0.05
|
| Long Term Capital Lease Obligation |
|
0.50
-43.51%
|
0.88
-27.20%
|
1.21
+2133.33%
|
0.05
|
| Defined Pension Benefit |
|
0.39
-33.95%
|
0.59
-4.95%
|
0.63
-16.42%
|
0.75
|
| Non Current Pension And Other Postretirement Benefit Plans |
|
0.44
-47.30%
|
0.83
-8.96%
|
0.92
-11.34%
|
1.03
|
| Stockholders Equity |
|
22.81
-20.93%
|
28.85
-25.34%
|
38.64
-8.45%
|
42.21
|
| Common Stock Equity |
|
22.81
-20.93%
|
28.85
-25.34%
|
38.64
-8.45%
|
42.21
|
| Capital Stock |
|
0.77
+0.00%
|
0.77
+0.00%
|
0.77
+21.32%
|
0.64
|
| Common Stock |
|
0.77
+0.00%
|
0.77
+0.00%
|
0.77
+21.32%
|
0.64
|
| Share Issued |
|
2.79
+0.01%
|
2.79
+0.00%
|
2.79
+20.44%
|
2.31
|
| Ordinary Shares Number |
|
2.79
+0.01%
|
2.79
+0.00%
|
2.79
+20.44%
|
2.31
|
| Additional Paid In Capital |
|
259.05
+0.03%
|
258.96
+0.30%
|
258.17
+10.03%
|
234.64
|
| Retained Earnings |
|
-237.01
-2.65%
|
-230.88
-4.80%
|
-220.30
-14.11%
|
-193.06
|
| Total Equity Gross Minority Interest |
|
22.81
-20.93%
|
28.85
-25.34%
|
38.64
-8.45%
|
42.21
|
| Total Capitalization |
|
22.81
-20.93%
|
28.85
-25.34%
|
38.64
-8.45%
|
42.21
|
| Working Capital |
|
20.80
-20.03%
|
26.01
-29.02%
|
36.65
-7.76%
|
39.73
|
| Invested Capital |
|
22.81
-20.93%
|
28.85
-25.34%
|
38.64
-8.45%
|
42.21
|
| Total Debt |
|
0.99
-24.24%
|
1.31
-20.87%
|
1.65
+114.12%
|
0.77
|
| Capital Lease Obligations |
|
0.99
-24.24%
|
1.31
-20.87%
|
1.65
+114.12%
|
0.77
|
| Net Tangible Assets |
|
22.81
-20.93%
|
28.85
-25.34%
|
38.64
-8.45%
|
42.21
|
| Tangible Book Value |
|
22.81
-20.93%
|
28.85
-25.34%
|
38.64
-8.45%
|
42.21
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
0.32
+102.32%
|
-13.89
+21.66%
|
-17.73
-86.95%
|
-9.48
|
| Cash Flow From Continuing Operating Activities |
|
0.32
+102.32%
|
-13.89
+21.66%
|
-17.73
-86.95%
|
-9.48
|
| Net Income From Continuing Operations |
|
-6.13
+42.09%
|
-10.58
+61.16%
|
-27.24
-82.52%
|
-14.92
|
| Depreciation Amortization Depletion |
|
0.11
-53.22%
|
0.23
-31.87%
|
0.34
-39.15%
|
0.56
|
| Depreciation |
|
0.11
-53.22%
|
0.23
-31.87%
|
0.34
-39.15%
|
0.56
|
| Depreciation And Amortization |
|
0.11
-53.22%
|
0.23
-31.87%
|
0.34
-39.15%
|
0.56
|
| Other Non Cash Items |
|
0.29
+721.74%
|
-0.05
-137.10%
|
0.12
+137.92%
|
-0.33
|
| Pension And Employee Benefit Expense |
|
-0.19
-276.47%
|
-0.05
-950.00%
|
0.01
-70.00%
|
0.02
|
| Stock Based Compensation |
|
0.08
-89.57%
|
0.79
-57.72%
|
1.86
+21.74%
|
1.53
|
| Operating Gains Losses |
|
-0.25
-347.27%
|
-0.06
-12.24%
|
-0.05
-345.00%
|
0.02
|
| Unrealized Gain Loss On Investment Securities |
|
0.03
-85.14%
|
0.17
+140.14%
|
-0.44
-466.39%
|
0.12
|
| Gain Loss On Sale Of PPE |
|
-0.05
-1250.00%
|
-0.00
+92.73%
|
-0.06
|
0.00
|
| Change In Working Capital |
|
6.19
+240.66%
|
-4.40
-157.41%
|
7.67
+116.73%
|
3.54
|
| Change In Receivables |
|
2.60
+161.94%
|
-4.20
-155.69%
|
7.54
-39.88%
|
12.55
|
| Changes In Account Receivables |
|
1.63
+150.53%
|
-3.22
-142.66%
|
7.54
-39.88%
|
12.55
|
| Change In Prepaid Assets |
|
2.77
+382.36%
|
-0.98
+26.79%
|
-1.34
-89.00%
|
-0.71
|
| Change In Payables And Accrued Expense |
|
0.82
+5.13%
|
0.78
-46.76%
|
1.47
+117.65%
|
-8.30
|
| Change In Payable |
|
0.82
+5.13%
|
0.78
-46.76%
|
1.47
+117.65%
|
-8.30
|
| Change In Account Payable |
|
0.82
+5.13%
|
0.78
-46.76%
|
1.47
+117.65%
|
-8.30
|
| Change In Other Working Capital |
|
—
|
—
|
—
|
-0.17
|
| Investing Cash Flow |
|
-8.58
-132.14%
|
26.69
+373.99%
|
-9.74
-673.40%
|
1.70
|
| Cash Flow From Continuing Investing Activities |
|
-8.58
-132.14%
|
26.69
+373.99%
|
-9.74
-673.40%
|
1.70
|
| Net PPE Purchase And Sale |
|
0.01
+75.00%
|
0.00
+106.67%
|
-0.06
+64.91%
|
-0.17
|
| Purchase Of PPE |
|
-0.05
-2250.00%
|
-0.00
+98.51%
|
-0.13
+21.64%
|
-0.17
|
| Sale Of PPE |
|
0.05
+800.00%
|
0.01
-91.89%
|
0.07
|
0.00
|
| Capital Expenditure |
|
-0.05
-2250.00%
|
-0.00
+98.51%
|
-0.13
+21.64%
|
-0.17
|
| Net Investment Purchase And Sale |
|
-8.59
-132.18%
|
26.69
+375.65%
|
-9.68
-617.75%
|
1.87
|
| Purchase Of Investment |
|
-14.11
|
0.00
+100.00%
|
-23.98
-139.63%
|
-10.01
|
| Sale Of Investment |
|
5.52
-79.31%
|
26.69
+86.69%
|
14.29
+20.37%
|
11.88
|
| Net Other Investing Changes |
|
—
|
—
|
—
|
0.01
|
| Financing Cash Flow |
|
0.01
|
0.00
-100.00%
|
21.81
+145300.00%
|
0.01
|
| Cash Flow From Continuing Financing Activities |
|
0.01
|
0.00
-100.00%
|
21.81
+145300.00%
|
0.01
|
| Net Common Stock Issuance |
|
0.00
|
0.00
-100.00%
|
21.54
|
0.00
|
| Proceeds From Stock Option Exercised |
|
0.01
|
0.00
-100.00%
|
0.27
+1686.67%
|
0.01
|
| Changes In Cash |
|
-8.25
-164.45%
|
12.80
+326.12%
|
-5.66
+27.13%
|
-7.77
|
| Effect Of Exchange Rate Changes |
|
-0.19
-18700.00%
|
-0.00
+98.63%
|
-0.07
-154.89%
|
0.13
|
| Beginning Cash Position |
|
20.66
+162.81%
|
7.86
-42.18%
|
13.60
-35.96%
|
21.23
|
| End Cash Position |
|
12.22
-40.84%
|
20.66
+162.81%
|
7.86
-42.18%
|
13.60
|
| Free Cash Flow |
|
0.28
+101.98%
|
-13.89
+22.24%
|
-17.86
-85.02%
|
-9.65
|
| Income Tax Paid Supplemental Data |
|
—
|
—
|
0.00
|
0.00
|
| Common Stock Issuance |
|
0.00
|
0.00
-100.00%
|
21.54
|
0.00
|
| Issuance Of Capital Stock |
|
0.00
|
0.00
-100.00%
|
21.54
|
0.00
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|